Mirae Asset Global Investments Co., Ltd. Xenon Pharmaceuticals Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,541 shares of XENE stock, worth $87,054. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,541
Previous 2,740
7.26%
Holding current value
$87,054
Previous $107,000
7.48%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
66.7MCall Options Held
109KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$194 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$155 Million1.73% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$99.8 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$98.2 Million0.06% of portfolio
-
Commodore Capital LP New York, NY2.74MShares$93.9 Million10.76% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.13B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...